Format

Send to

Choose Destination
Am J Surg. 1995 Oct;170(4):319-22.

A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery.

Author information

1
University Department of Surgery, Royal Infirmary, Glasgow, United Kingdom.

Abstract

BACKGROUND:

Approximately 70% of patients who are going to develop tumor recurrence following curative colorectal surgery do so within 24 months of surgery.

PATIENTS AND METHODS:

The relationship was prospectively examined between an ongoing acute-phase response and subsequent clinical relapse in 36 colorectal cancer patients who had undergone a curative resection. Approximately 4 months after their operation, patients were grouped according to the presence (n = 15) or absence (n = 21) of an acute-phase response (C-reactive protein > 5 mg/L) and were followed-up for a minimum of 24 months.

RESULTS:

Age, tumor site, and serum carcinoembryonic antigen concentrations were similar in both groups. There was a significantly higher recurrence rate in patients with an acute-phase response (11 of 15) compared to those with no acute-phase response (2 of 21, P < 0.01).

CONCLUSIONS:

These results are consistent with the presence of an acute-phase response being an important predictive factor in the early stages of tumor recurrence in patients who have had apparently curative colorectal surgery.

PMID:
7573721
DOI:
10.1016/s0002-9610(99)80296-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center